Details

NameSymbolSector
AUROBINDO PHARMA LTD.AUROPHARMAPharmaceuticals
Open
1677.9
High
1681.7
Low
1655
Close
1666.9
Volume
796734
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

1.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Aurobindo Pharma is  
Short Body
Estimated Stoploss of Aurobindo Pharma is ₹  
1681.7
Aurobindo Pharma has a  
Bearishℹ
 pattern. 
Formation of  
Short Body
 candle pattern indicates the trend direction of Aurobindo Pharma is  
Unpredictableℹ
. 

Trend

Aurobindo Pharma is in  
Sideways trendℹ
. 
Price of Aurobindo Pharma is  
Upℹ
 by  

0.79

%. 
Target
Buy @ 

1512.03

Sell @ 

1740.95

Current @ 

1666.9

Volume

The trade volumes of Aurobindo Pharma have been  
Underperformingℹ
Though the volume trend for Aurobindo Pharma appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Aurobindo Pharma is  

Down

 by  

9.37

% 

Valuation

The current market price of Aurobindo Pharma is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 49784cr and total assets worth ₹ 49784cr, the balance sheet of Aurobindo Pharma is:  
Balancedℹ
. 
Cashflow
Aurobindo Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 2178cr

. It is  
Upℹ
 by  

316.5

%. 

(*Mar 2025)

66.21% i.e. ₹ 3924cr earned in operatingℹ
31.63% i.e. ₹ 1875cr spent in investingℹ
2.01% i.e. ₹ 119cr earned in financingℹ
0.15% i.e. ₹ 9cr earned in otherℹ
Aurobindo Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 1006cr

. It is  
Downℹ
 by  

539.3

%. 

(*Mar 2024)

32.44% i.e. ₹ 2434cr earned in operatingℹ
56.71% i.e. ₹ 4255cr spent in investingℹ
10.66% i.e. ₹ 800cr earned in financingℹ
0.19% i.e. ₹ 14cr earned in otherℹ
Income
The income of Aurobindo Pharma is  

₹ 8406cr

 and  

Profit

 is :  

₹ 846cr

(*Sep 2025)

Aurobindo Pharma Profit is up by:  

2.92

% and Income is Up by:  

5.43

% 

(*Sep 2025)

The income of Aurobindo Pharma is  

₹ 7973cr

 and  

Profit

 is :  

₹ 822cr

(*Jun 2025)

Aurobindo Pharma Profit is down by:  

12.09

% and Income is Down by:  

6.38

% 

(*Jun 2025)

The income of Aurobindo Pharma is  

₹ 8516cr

 and  

Profit

 is :  

₹ 935cr

(*Mar 2025)

Aurobindo Pharma Profit is up by:  

10.91

% and Income is Up by:  

4.68

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.